Snus is banned in most countries not because it’s the most dangerous tobacco product, but because regulators decided decades ago to prevent a new form of tobacco addiction from gaining a foothold. The European Union prohibited the sale of tobacco products for oral use in 1992, and that ban remains the foundation of snus laws in most of Europe and the UK today. The reasoning centers on public health precaution: rather than wait to see whether snus would create new tobacco users, especially among young people, governments chose to block it outright.
The EU Ban and How It Started
The ban traces back to the early 1990s, when the EU passed legislation prohibiting tobacco products designed for oral use. At the time, snus was virtually unknown outside Scandinavia, and European health authorities worried that allowing it onto the market would introduce a new route to nicotine addiction across the continent. The logic was straightforward: cigarettes were already a massive public health burden, and adding another tobacco product to store shelves could make the problem worse rather than better.
When Sweden joined the EU in 1995, it negotiated a specific exemption. Snus had been part of Swedish culture for centuries, and removing it was politically impossible. Sweden received a permanent derogation from the ban, allowing snus to remain on sale domestically. No other EU member state has that exemption. Norway, which isn’t an EU member, also allows snus sales.
Why Courts Have Upheld the Ban
The ban has been legally challenged. In 2018, the Court of Justice of the European Union ruled definitively that the prohibition does not violate principles of free trade, proportionality, or non-discrimination. The court found the ban justified on public health grounds and the need to protect young people, and stated it does not constitute a disproportionate restriction on the free movement of goods. That ruling effectively closed the door on legal challenges within the EU framework.
Critics of the ban argue it’s inconsistent. Cigarettes, which kill roughly half of long-term users, remain legal and widely available. Chewing tobacco and other smokeless products are sold in some EU countries. Singling out snus while permitting far more harmful products strikes many public health researchers as illogical. But the court’s position is that preventing a new category of tobacco product from entering the market is a legitimate regulatory goal, even if existing products remain legal.
The UK Kept the Ban After Brexit
Tobacco-containing snus has been banned in the UK since 1992 under the Tobacco for Oral Use (Safety) Regulations. That law originated from EU legislation, and it stayed in place after Brexit. The ban covers England, Scotland, Wales, and Northern Ireland. Despite occasional calls to revisit the policy, particularly from harm reduction advocates, the UK government has not moved to legalize snus.
Tobacco-free nicotine pouches, however, are a different story. Because they contain no tobacco leaf, they fall outside the scope of the snus ban. Products like Zyn and Velo are legal to buy and sell throughout the UK. The distinction is entirely about the presence of tobacco, not nicotine itself.
Snus Is Legal in the United States
The US never banned snus. It’s regulated as a smokeless tobacco product by the FDA, subject to the same rules as chewing tobacco and other oral tobacco products. In 2019, the FDA went a step further and granted one brand, General Snus, a “modified risk” designation. This allows the company to market the product with a specific authorized claim: that using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis. That designation is the first of its kind for any smokeless tobacco product and comes with requirements for ongoing surveillance and reporting through 2032.
What the Health Data Actually Shows
The health picture for snus is genuinely complicated, which is part of why the regulatory debate is so heated. Snus is not harmless, but it’s far less dangerous than cigarettes. A large cohort study of male construction workers published in The Lancet found snus use was associated with roughly double the risk of pancreatic cancer compared to people who never used any tobacco. But the same study found no increased risk of oral cancer or lung cancer among snus users.
Cardiovascular effects are more nuanced. According to an American Heart Association review, most Swedish studies have found that snus use is linked to increased mortality from heart attacks and strokes, but not to a higher rate of those events occurring in the first place. In other words, snus doesn’t appear to accelerate the buildup of artery disease, but it may make existing heart conditions more deadly. One study found that snus users hospitalized with a heart attack who quit using snus had lower mortality over the following two years compared to those who kept using it. The likely mechanism is nicotine’s effect on heart rhythm during episodes of reduced blood flow to the heart.
The chemical profile helps explain why snus is less harmful than cigarettes but not risk-free. Snus contains tobacco-specific nitrosamines, compounds that form during tobacco processing and are known carcinogens. A single snus pouch can contain up to 1,190 nanograms of one key nitrosamine (NNN) and 120 nanograms of another (NNK). Cigarette smoke delivers comparable amounts per cigarette. Tobacco-free nicotine pouches, by contrast, contain far lower levels: the highest measurements found were 13 nanograms of NNN and 5.4 nanograms of NNK per pouch.
The Harm Reduction Debate
Sweden’s experience is the strongest argument in favor of legalizing snus. The country has the lowest smoking rate in Europe, hovering around 5%, and many public health researchers credit snus as the primary reason. Swedish men in particular switched from cigarettes to snus in large numbers over several decades, and Sweden’s rates of lung cancer and smoking-related death reflect that shift. Advocates point to this as real-world proof that snus works as a harm reduction tool.
The World Health Organization disagrees with framing any tobacco product as harm reduction. The WHO’s position is that all tobacco and nicotine products pose health risks, including the risk of addiction, and that harm reduction arguments should never justify lighter regulation. The organization recommends proven cessation methods rather than switching to alternative products “designed to sustain addiction.”
This fundamental disagreement is why the ban persists. One side sees snus as a less harmful alternative that could save lives by pulling smokers away from cigarettes. The other side sees legalizing any new tobacco product as opening a door that’s difficult to close, particularly when it comes to younger users who might start with snus rather than switching from cigarettes. EU regulators have consistently sided with the precautionary approach, and the 2018 court ruling suggests that position isn’t changing anytime soon.
Why Nicotine Pouches Aren’t Banned
If you’ve seen products like Zyn on shelves in countries where snus is illegal, the distinction comes down to one ingredient: tobacco. Snus contains ground tobacco leaf. Nicotine pouches are made from plant fibers, synthetic or extracted nicotine, flavorings, and stabilizers. Because the EU ban specifically targets “tobacco products for oral use,” tobacco-free pouches fall outside its scope. They deliver nicotine in a similar way, and users often can’t tell much difference in practice, but legally they’re an entirely separate category. Several countries are now moving to regulate nicotine pouches more tightly, with age restrictions and packaging rules, but outright bans remain rare.